More than two dozen life science, pharmaceutical and biotech organizations partnered Oct. 4 to build a coalition advocating for mergers and acquisitions in the life sciences industry.
Read the full post on Becker's Hospital Review - Healthcare News
31 drugmakers, biotechs form pro-M&A group
